Related Experiment Video
Updated: Dec 27, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
MircoRNA-129-5p suppresses the development of glioma by targeting HOXC10
Jin Liu1, Chao Cheng1, Jiantong Jiao1
1Department of Neurosurgery, Wuxi People's Hospital of Nanjing Medical University, Wuxi, 214023, Jiangsu, China.
Background:
miR-129-5p has been reported to be abnormally expressed and plays an important role in the progression of various malignancies. However, its role in gliomas and its exact molecular mechanism need further research.
Methods And Materials:
RT-qPCR was performed to evaluate miR-129-5p and HOXC10 mRNA expression levels in tissues and cell lines. Cell proliferation was detected via Cell Counting Kit-8 (CCK-8), 5-ethynyl-2'-deoxyuridine (EdU) and clone formation assays. Luciferase assays were used to validate the binding of seeds between miR-129-5p and HOXC10. A tumor xenograft model was developed to study the effect of miR-129-5p on glioma growth in vivo.
Results:
miR-129-5p was expressed at low levels in glioma tissues and cell lines. miR-129-5p overexpression inhibited glioma proliferation, migration and invasion. miR-129-5p negatively and directly targeted HOXC10. At the same time, HOXC10 was upregulated in glioma cancer, and HOXC10 knockdown inhibited cell proliferation, migration and invasion.
Conclusion:
miR-129-5p inhibits glioma development by altering HOXC10 expression and may therefore serve as a new diagnostic marker and therapeutic target for glioma in the future.
Insights
MicroRNA-129-5p (miR-129-5p) inhibits glioma progression by targeting HOXC10. This finding suggests miR-129-5p as a potential diagnostic marker and therapeutic target for glioma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-129-5p (miR-129-5p) is implicated in various cancers but its role in gliomas requires further investigation.
- The precise molecular mechanisms underlying miR-129-5p's function in glioma remain unclear.
Purpose of the Study:
- To elucidate the role and molecular mechanism of miR-129-5p in glioma.
- To investigate the potential of miR-129-5p as a diagnostic marker and therapeutic target for glioma.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) to assess miR-129-5p and HOXC10 expression.
- In vitro assays (CCK-8, EdU, clone formation) to evaluate cell proliferation, migration, and invasion.
- Luciferase assays to confirm direct targeting of HOXC10 by miR-129-5p.
- In vivo tumor xenograft model to assess the impact of miR-129-5p on glioma growth.
Main Results:
- miR-129-5p expression was significantly downregulated in glioma tissues and cell lines.
- Overexpression of miR-129-5p suppressed glioma cell proliferation, migration, and invasion.
- miR-129-5p directly targets HOXC10, which is upregulated in gliomas.
- Knockdown of HOXC10 inhibited glioma cell proliferation, migration, and invasion.
Conclusions:
- miR-129-5p exerts tumor-suppressive effects in glioma by downregulating HOXC10.
- miR-129-5p represents a promising diagnostic biomarker and therapeutic strategy for glioma.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Experimental RNAi

